Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.85% | 4.33% | |||
| Total Other Revenue | 10.71% | 16.67% | |||
| Total Revenue | 1.95% | 4.45% | |||
| Cost of Revenue | 4.45% | -3.20% | |||
| Gross Profit | 0.99% | 7.72% | |||
| SG&A Expenses | -4.00% | 2.16% | |||
| Depreciation & Amortization | -5.47% | 1.48% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.05% | -0.71% | |||
| Operating Income | 9.19% | 28.61% | |||
| Income Before Tax | 1,095.24% | -143.75% | |||
| Income Tax Expenses | 56.34% | 44.90% | |||
| Earnings from Continuing Operations | 206.52% | -9,100.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -171.43% | -36.36% | |||
| Net Income | 209.41% | -950.00% | |||
| EBIT | 9.19% | 28.61% | |||
| EBITDA | 4.04% | 16.87% | |||
| EPS Basic | 208.37% | -948.16% | |||
| Normalized Basic EPS | 8.56% | 146.51% | |||
| EPS Diluted | 208.37% | -948.16% | |||
| Normalized Diluted EPS | 8.56% | 148.01% | |||
| Average Basic Shares Outstanding | 0.98% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.98% | -0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
